Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Innovative Eyewear, Inc. (LUCY)
USD0.84
-0.12 (-12.48%)
US NASDAQ Healthcare Medical - Instruments & Supplies
Address
11900 Biscayne Boulevard 33181
North Miami, FL, US
North Miami, FL, US
CEO
Harrison Reed Gross
Website
lucyd.co
IPO
2022-08-15
CIK 1808377 ISIN US45791D2080
Also trades on
NASDAQ Capital Market · LUCY (USD)
NASDAQ Capital Market · LUCYW (USD)
Description
Innovative Eyewear, Inc. specializes in the design and commercialization of intelligent eyewear, encompassing both eyeglasses and sunglasses. Central to its product line is Lucyd Lyte, a pair of smart glasses empowering users to engage with audio content, manage phone conversations, and activate smartphone functions hands-free through voice commands. Additionally, the company provides Vyrb, a social media application facilitating the vocal exchange of posts directly through Lucyd Lyte smart glasses. Its offerings reach consumers via diverse e-commerce platforms and traditional retail outlets. Established in 2019 and headquartered in North Miami, Florida, Innovative Eyewear, Inc. operates as a subsidiary of Lucyd Ltd., reflecting its close collaboration with the latter.
News Sentiment (7d)
6 articles
- Innovative Eyewear Stock Climbs as Canada Launch Adds Fuel to Sales Growth Story Benzinga
- Innovative Eyewear Q2 2026 Net Sales Up 71% Year-Over-Year in Twelfth Consecutive Quarter of Growth PRNewsWire
- Innovative Eyewear, Inc. Announces Exercise of Warrants For Approximately $3.0 Million in Gross Proceeds GuruFocus
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.84
-0.12 (-12.48%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
78.1K
Beta
2.70
Float Shares
1.93M
Free Float %
48.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -7.92% | -9.71% | -12.26% | -19.13% | -42.24% | -6.67% | -65.56% | -97.53% | -99.21% | -99.21% | -99.21% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (1 ratings, all time)
Buy
Price Targets & DCF
Current price
0.84
DCF (Unlevered)
1,701.36
+202,877.9%
DCF (Levered)
1,608.26
+191,770.9%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-4.40
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
0 / 10
No MOAT
Composite Rating
D+
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Instruments & Supplies: +7.9%+62.7% ★ Q1'26: +70.2% (vs Q1'25)
-
EPS growth Medical - Instruments & Supplies: +16.3%+63.4% ★ Q1'26: +48.6% (vs Q1'25)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%-342.9% Q1'26: -322.0% (vs Q1'25)
-
EBIT margin Medical - Instruments & Supplies: +13.5%-319.2% Q1'26: -306.6% (vs Q1'25)
-
ROIC Medical - Instruments & Supplies: +6.0%-0.3% Q1'26: -234.6% (vs Q1'25)
-
Share dilution Medical - Instruments & Supplies: +0.1%+166.8% Q1'26: +317.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×0.00× Q1'26: -0.02× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|
| Revenue |
1.15M
est: 700.0K (+64.6%)
|
1.64M
est: 1.60M (+2.3%)
|
2.66M
est: 2.90M (-8.2%)
|
7.20M
7.20M – 7.20M
+148.3% YoY
|
22.00M
22.00M – 22.00M
+205.6% YoY
|
| EBITDA |
-6.58M
est: -700.0K (-839.3%)
|
-7.62M
est: -1.60M (-376.1%)
|
-8.36M
est: -2.90M (-188.3%)
|
-7.20M
-7.20M – -7.20M
-148.3% YoY
|
-22.00M
-22.00M – -22.00M
-205.6% YoY
|
| EBIT |
-6.66M
est: -700.0K (-851.5%)
|
-7.77M
est: -1.60M (-385.4%)
|
-8.49M
est: -2.90M (-192.9%)
|
-7.20M
-7.20M – -7.20M
-148.3% YoY
|
-22.00M
-22.00M – -22.00M
-205.6% YoY
|
| Net Income |
-6.66M
est: -17.96M (+62.9%)
|
-7.77M
est: -20.72M (+62.5%)
|
-7.59M
est: -8.74M (+13.2%)
|
-5.79M
-5.79M – -5.79M
+33.8% YoY
|
-1.80M
-1.80M – -1.80M
+69.0% YoY
|
| SGA |
5.93M
est: 4.16M (+42.7%)
|
7.18M
est: 277.93M (-97.4%)
|
2.25B
est: 503.76M (+347.6%)
|
1.25B
1.25B – 1.25B
+148.3% YoY
|
3.82B
3.82B – 3.82B
+205.6% YoY
|
| EPS |
-12.67
est: -12.00 (-5.6%)
|
-5.19
est: -5.19 (+0.0%)
|
-1.90
est: -2.19 (+13.2%)
|
-1.45
-1.45 – -1.45
+33.8% YoY
|
-0.45
-0.45 – -0.45
+69.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-12 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-11 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-08 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-07 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-06 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-05 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-04 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-01 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-30 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-29 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-28 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-27 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-24 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-23 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-22 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-21 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-20 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
3.08B
OE per share TTM
561.81
Owner's Yield
52,992.47%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
906.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
3
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Daniel B. Asher | 1.04M | 5.90% | — | 1.04M | — | 958.3K | HC, IN | United States of America | 2024-05-09 | ↗ |
| 2 | Intracoastal Capital LLC | 1.04M | 5.90% | — | 1.04M | — | 958.3K | OO | United States of America | 2024-05-09 | ↗ |
| 3 | Mitchell P. Kopin | 1.04M | 5.90% | — | 1.04M | — | 958.3K | HC, IN | United States of America | 2024-05-09 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
1.67
Bullish
Ratio by volume
0.01
Bearish
Buys
5
Sells
3
Shares acquired
5.3K
Shares disposed
648.8K
Cash buys
8.00
Cash sales
—
Net activity
-643,467
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-21 | Gross Harrison R. | Director / Officer | P-Purchase | A | Common Stock | 1,500 | 1.32 | 2.0K | 13,733 | D | ↗ |
| 2026-01-13 | Gayle Oswald | Officer | P-Purchase | A | Common Stock | 300 | 1.69 | 507.00 | 2,865 | D | ↗ |
| 2026-01-08 | Gross Harrison R. | Director / Officer | P-Purchase | A | Common Stock | 1,500 | 1.60 | 2.4K | 12,233 | D | ↗ |
| 2026-01-08 | Dabrowski Konrad | Officer | P-Purchase | A | Common Stock | 1,300 | 1.58 | 2.1K | 12,804 | D | ↗ |
| 2026-01-07 | Galkin Vladimir | 10% Owner | P-Purchase | D | Common Stock, par value $0.00001 | 643,505 | 1.79 | 1.15M | 0 | D | ↗ |
| 2026-01-02 | Galkin Vladimir | 10% Owner | P-Purchase | D | Common Stock, par value $0.00001 | 1,262 | 0.97 | 1.2K | 647,505 | D | ↗ |
| 2025-12-31 | Gross Harrison R. | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-12-31 | Gayle Oswald | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-12-31 | Galkin Vladimir | 10% Owner | P-Purchase | D | Common Stock, par value $0.00001 | 89,830 | 0.99 | 88.9K | 648,767 | D | ↗ |
| 2025-12-31 | Dabrowski Konrad | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-12-31 | Cohen David Eric | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-12-31 | Abondano Joaquin | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-12-30 | Galkin Vladimir | 10% Owner | P-Purchase | D | Common Stock, par value $0.00001 | 11,303 | 1.08 | 12.2K | 738,597 | D | ↗ |
| 2025-12-29 | Galkin Vladimir | 10% Owner | P-Purchase | D | Common Stock, par value $0.00001 | 46,107 | 1.10 | 50.7K | 749,900 | D | ↗ |
| 2025-12-26 | Galkin Vladimir | 10% Owner | P-Purchase | D | Common Stock, par value $0.00001 | 90,709 | 1.22 | 110.7K | 796,007 | D | ↗ |
| 2025-12-24 | Galkin Vladimir | 10% Owner | P-Purchase | D | Common Stock, par value $0.00001 | 928 | 1.31 | 1.2K | 886,716 | D | ↗ |
| 2025-12-23 | Galkin Vladimir | 10% Owner | P-Purchase | D | Common Stock, par value $0.00001 | 32,958 | 1.33 | 43.8K | 887,644 | D | ↗ |
| 2025-12-22 | Galkin Vladimir | 10% Owner | P-Purchase | D | Common Stock, par value $0.00001 | 367 | 1.35 | 495.45 | 920,602 | D | ↗ |
| 2025-12-19 | Galkin Vladimir | 10% Owner | P-Purchase | D | Common Stock, par value $0.00001 | 4,835 | 1.37 | 6.6K | 920,969 | D | ↗ |
| 2025-12-18 | Galkin Vladimir | 10% Owner | P-Purchase | D | Common Stock, par value $0.00001 | 7,600 | 1.38 | 10.5K | 925,804 | D | ↗ |
| 2025-12-17 | Galkin Vladimir | 10% Owner | P-Purchase | D | Common Stock, par value $0.00001 | 5,366 | 1.38 | 7.4K | 933,404 | D | ↗ |
| 2025-12-11 | Galkin Vladimir | 10% Owner | P-Purchase | D | Common Stock, par value $0.00001 | 8,423 | 1.58 | 13.3K | 938,770 | D | ↗ |
| 2025-12-10 | Galkin Vladimir | 10% Owner | P-Purchase | D | Common Stock, par value $0.00001 | 50,300 | 1.49 | 74.9K | 947,193 | D | ↗ |
| 2025-12-04 | Galkin Vladimir | 10% Owner | P-Purchase | D | Common Stock, par value $0.00001 | 2,507 | 1.50 | 3.8K | 997,493 | D | ↗ |
| 2024-10-11 | Gayle Oswald | Officer | — | — | Employee Stock Option representing right to buy common stock | 4,500 | 25.00 | 112.5K | 0 | D | ↗ |
| 2024-09-23 | Galkin Vladimir | 10% Owner | P-Purchase | A | Common Stock, par value $0.00001 | 33,273 | 8.61 | 286.5K | 1,000,000 | I | ↗ |
| 2024-09-20 | Galkin Vladimir | 10% Owner | S-Sale | D | Common Stock, par value $0.00001 | 3,245 | 10.00 | 32.5K | 799,208 | I | ↗ |
| 2024-09-19 | Galkin Vladimir | 10% Owner | S-Sale | D | Common Stock, par value $0.00001 | 780 | 9.79 | 7.6K | 784,793 | I | ↗ |
| 2024-09-18 | Galkin Vladimir | 10% Owner | P-Purchase | A | Common Stock, par value $0.00001 | 17,805 | 7.47 | 132.9K | 531,087 | I | ↗ |
| 2024-09-17 | Galkin Vladimir | 10% Owner | P-Purchase | A | Common Stock, par value $0.00001 | 2,841 | 7.65 | 21.7K | 401,752 | I | ↗ |
| 2024-09-16 | Galkin Vladimir | 10% Owner | — | — | Common Stock | 0 | 0.00 | — | 331,747 | I | ↗ |
| 2024-08-19 | Gross Harrison R. | Director / Officer | P-Purchase | A | Common Stock | 500 | 3.68 | 1.8K | 500 | — | ↗ |
| 2023-12-18 | Gross Harrison R. | Director / Officer | A-Award | A | Option | 150,000 | 0.45 | 67.5K | 150,000 | — | ↗ |
| 2023-12-18 | Dabrowski Konrad | Officer | A-Award | A | Option | 120,000 | 0.45 | 54.0K | 120,000 | — | ↗ |
| 2023-12-18 | Cohen David Eric | Officer | A-Award | A | Option | 70,000 | 0.45 | 31.5K | 70,000 | — | ↗ |
| 2023-12-18 | Abondano Joaquin | Officer | — | D | Options | 70,000 | 0.45 | 31.5K | 0 | — | ↗ |
| 2023-01-13 | Mclaughlin Kristen | Director | A-Award | A | Option | 20,000 | 1.28 | 25.5K | 20,000 | — | ↗ |
| 2023-01-13 | Gross Harrison R. | Director / Officer | A-Award | A | Option | 90,000 | 1.28 | 114.8K | 90,000 | — | ↗ |
| 2023-01-13 | Dabrowski Konrad | Officer | A-Award | A | Option | 90,000 | 1.28 | 114.8K | 90,000 | — | ↗ |
| 2023-01-13 | Cohen David Eric | Officer | A-Award | A | Option | 60,000 | 1.28 | 76.5K | 60,000 | — | ↗ |
| 2023-01-13 | Castro Louis | Director | A-Award | A | Option | 35,000 | 1.28 | 44.6K | 35,000 | — | ↗ |
| 2023-01-13 | Bartlett Olivia C. | Director | A-Award | A | Option | 20,000 | 1.28 | 25.5K | 20,000 | — | ↗ |
| 2023-01-13 | Abondano Joaquin | Officer | — | D | Non-Qualified Stock Option | 60,000 | 1.28 | 76.5K | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-7.7K
Shares Outstanding
3.99M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Harrison Reed Gross | Co-Founder, Chief Executive Officer & Director | 207.1K | male |
| David Cohen | Co-Founder & Chief Technology Officer | 172.3K | male |
| Oswald Anthony Gayle | Chief Financial Officer | 156.3K | male |
| Konrad Dabrowski | Co-Founder and Chief AI & Growth Officer | 114.0K | male |
| Jaoquin Abondano | Chief Operating Officer | — | male |
ESG Rating
ESG Score History MEDICAL - INSTRUMENTS & SUPPLIES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for LUCY
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
